AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

THE REAL MOST ACTIVE Nasdaq Gives Up 1.1%; Medicals Lose Ground.(B)

Investor's Business Daily

| August 04, 2003 | COPYRIGHT 2003 Investor's Business Daily, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Byline: NANCY GONDO

Nasdaq stocks opened higher Friday, but pulled back later in the session to close near their intraday low on much lower volume. Most medical groups had a particularly bad day. The composite slid 1.1% and the Nasdaq 100 1.0%.

Sonosite plunged 6.19 to 15.80 on its heaviest trade of the year as more than 2.4 million shares changed hands. Shares pierced their 200-day moving average for the first time since early March. The ultrasound imaging device maker lost 9 cents a share in the second quarter, better than last year's 20-cent loss but well below views for a 1-cent profit.

Drug maker Cima fell 2.46, or 8.6%, to 26.12 on triple average volume. The stock has closed below its 50-day line for 10 of the past 11 sessions. Late Thursday the firm announced a second-quarter profit of 22 cents a share, up 29% from a year ago but 3 cents off views. It expects 24-27 cents in the third quarter, below forecasts for 29 cents.

Among other drug makers, Shire Pharmaceuticals shed 0.63 to 22.80 and Penwest Pharmaceuticals 0.66 to 22.51.

Equinix sank 4.44 to 14.61 on its biggest turnover of the year. Executives of the network services provider disclosed plans to ...

Related articles from newspapers, magazines, journals, and more
Drug Maker Pfizer May Reap Millions in Incentives from New Jersey.(Knight...
Newspaper article from: Knight Ridder/Tribune Business News April 21, 2000 700+ words
...officials are trying to entice the New York drug maker to limit local job cuts with incentives...Economic Growth Commission and the big drug maker, which is best known for its Viagra...will create the world's second largest drug maker, is expected to be finalized next month...
American drug maker IVAX considering paying cash for majority of Poland's Polfa...
Newspaper article from: Poland Business News April 26, 2004 700+ words
American drug maker IVAX considering paying cash for majority of Poland's Polfa Kutno Warsaw. April 26. INTERFAX-EUROPE - Drug maker IVAX, the sixth-biggest US generic-drug maker by number of prescriptions, under pressure from investors...
New Jersey-Based Drug Maker's Last-Minute Deluge Irks Plaintiffs' Lawyers.
Newspaper article from: Knight Ridder/Tribune Business News Silverman, Edward R. August 4, 1999 700+ words
...popular diet pills once sold by the Madison drug maker. Not all of the 38,000 or so newly...expected to shed additional light on the drug maker's knowledge of the serious heart and...action to go to trial in which the drug maker is being asked to pay for any future...
Drug maker Dainippon to buy Sepracor for $2.6 billion; Drug maker Dainippon to...
Newspaper article from: International Herald Tribune Chris V Nicholson September 4, 2009 700+ words
...International Herald Tribune 09-04-2009 Drug maker Dainippon to buy Sepracor for $2.6 billion; Drug maker Dainippon to buy Sepracor of U.S...Thursday that it would buy the U.S. drug maker Sepracor for $2.6 billion, as it...
Diet-Drug Maker's Settlement Includes Refunds, Checkups.
Newspaper article from: Knight Ridder/Tribune Business News Ornstein, Charles October 7, 1999 700+ words
...over its 16-year payout schedule. The drug maker, based in Madison, N.J., will set...hanging over the nation's fifth-largest drug maker in recent months, analysts said. The...associated with its diet drugs. The drug maker said the settlement contains no admission...
Polish drug maker Polpharma seeks top spot on domestic market, plans foreign...
Newspaper article from: Poland Business News January 22, 2003 700+ words
Polish drug maker Polpharma seeks top spot on domestic...January 22. INTERFAX-EUROPE - Polish drug maker Polpharma is seeking to oust Poland...By volume, it is still the biggest drug maker in Poland, producing 172 molecules...
Madison, N.J.-Based Drug Maker's Stock Drops in Wake of FBI Probe.
Newspaper article from: Knight Ridder/Tribune Business News Silverman, Edward R. September 9, 1999 700+ words
...The Star-Ledger, that the Madison drug maker is being probed by the Federal Bureau...regulators or acting improperly. The drug maker has also denied knowledge of an FBI inquiry...which a jury unexpectedly ordered the drug maker to pay $23 million to a woman. Until...
Drug Maker Pfizer Likely to Buy Warner-Lambert.(Knight Ridder/Tribune Business...
Newspaper article from: Knight Ridder/Tribune Business News Silverman, Edward R. February 7, 2000 700+ words
...will be the world's second-largest drug maker, but it could also spell trouble for...people work for Warner-Lambert at the drug maker's headquarters in Morris Plains. It...person familiar with Pfizer emphasized the drug maker makes many donations and will probably...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA